Comparative risk of infection for first line csDMARD therapy in rheumatoid arthritis: A multinational cohort analysis of real world data

Oct-20

AUTHORS : Dr Meghna Jani, Centre for Epidemiology Versus Arthritis, Second floor, Stopford Building, The University of Manchester, Oxford Road, Manchester M13 9PT – Email: meghna.jani@manchester.ac.uk – Profile: https://www.research.manchester.ac.uk/portal/meghna.jani.html

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 29(S3):610-611

DOI : 10.1002/pds.5114

Comparative risk of infection for first line csDMARD therapy in rheumatoid arthritis: A multinational cohort analysis of real world data

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study